SG Americas Securities LLC reduced its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 89.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 5,157 shares of the insurance provider’s stock after selling 45,574 shares during the period. SG Americas Securities LLC’s holdings in Humana were worth $2,504,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Arlington Partners LLC purchased a new stake in shares of Humana in the 4th quarter valued at $29,000. WFA of San Diego LLC bought a new position in shares of Humana during the fourth quarter valued at about $33,000. MV Capital Management Inc. increased its holdings in shares of Humana by 40.8% in the first quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock worth $33,000 after buying an additional 20 shares during the period. U.S. Capital Wealth Advisors LLC bought a new stake in shares of Humana in the 4th quarter valued at about $35,000. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new stake in Humana during the 1st quarter valued at about $39,000. 93.21% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on HUM. TheStreet upgraded Humana from a “c+” rating to a “b-” rating in a research report on Thursday, April 13th. Morgan Stanley reaffirmed an “overweight” rating and issued a $637.00 price target on shares of Humana in a research note on Friday, July 14th. Wells Fargo & Company lowered their price objective on Humana from $610.00 to $541.00 in a research report on Thursday, July 13th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Humana from $562.00 to $568.00 in a research note on Thursday, April 27th. Finally, Cantor Fitzgerald initiated coverage on shares of Humana in a research note on Thursday, April 20th. They set an “overweight” rating and a $597.00 price objective on the stock. Three analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Moderate Buy” and a consensus target price of $591.11.
Insider Buying and Selling
Humana Stock Up 2.1 %
HUM stock opened at $456.95 on Friday. The business’s 50-day moving average is $473.22 and its two-hundred day moving average is $492.46. The company has a market cap of $57.09 billion, a price-to-earnings ratio of 18.56, a P/E/G ratio of 1.13 and a beta of 0.67. Humana Inc. has a fifty-two week low of $423.29 and a fifty-two week high of $571.30. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.39 and a current ratio of 1.39.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 26th. The insurance provider reported $9.38 earnings per share for the quarter, topping the consensus estimate of $9.25 by $0.13. The business had revenue of $26.74 billion for the quarter, compared to analysts’ expectations of $26.40 billion. Humana had a net margin of 3.26% and a return on equity of 21.04%. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the company posted $8.04 EPS. As a group, analysts forecast that Humana Inc. will post 28.28 earnings per share for the current year.
About Humana
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- U.S. Bancorp Shares Rally As Analysts Get Bullish After Q2 Report
- AutoNation Beats Earnings Expectations, Stock Down?
- American Express Hiccups After Earnings, Time To Buy?
- ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?
- Winners And Losers In The Oilfield Supercycle
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
